Murine model of chronic respiratory inflammation

Advances in Experimental Medicine and Biology

Volumn 780, Issue , 2011, Pages 125-141

  Lugade, Amit A ^a   Bogner, Paul N ^a   Thanavala, Yasmin ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CIGARETTE SMOKE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BRONCHIOLITIS; CD8+ T LYMPHOCYTE; CHRONIC BRONCHITIS; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE EXACERBATION; HAEMOPHILUS INFLUENZAE; HERPES SIMPLEX VIRUS 1; HUMAN; INFECTION SENSITIVITY; INFLUENZA VIRUS; LEGIONELLA PNEUMOPHILA; LUNG ALVEOLUS MACROPHAGE; LUNG EMPHYSEMA; MIXED INFECTION; MORAXELLA CATARRHALIS; MUCOCILIARY CLEARANCE; MUCOSAL IMMUNITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT MUCOSA; STREPTOCOCCUS PNEUMONIAE; VIRUS REACTIVATION;

ANIMALS; BACTERIAL INFECTIONS; BRONCHI; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HAEMOPHILUS INFLUENZAE; HUMANS; INFLAMMATION; INTUBATION, INTRATRACHEAL; MICE; MORAXELLA (BRANHAMELLA) CATARRHALIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX; SMOKING; STREPTOCOCCUS PNEUMONIAE; TOBACCO SMOKE POLLUTION;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; MURINAE; NEGIBACTERIA; POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 80053610603     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5632-3_11     Document Type: Conference Paper

References (72)

1. Mizgerd JP (2006) Lung infection - a public health priority. PLoS Med 3:e76
2. Palm NW, Medzhitov R (2007) Not so fast: adaptive suppression of innate immunity. Nat Med 13:1142-1143
3. Didierlaurent A, Goulding J, Hussell T (2007) The impact of successive infections on the lung microenvironment. Immunology 122:457-465 (Pubitemid 350075963)
4. Chen HD, Fraire AE, Joris I, Welsh RM, Selin LK (2003) Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 163:1341-1355 (Pubitemid 37175083)
5. Beadling C, Slifka MK (2004) How do viral infections predispose patients to bacterial infections?. Curr Opin Infect Dis 17:185-191 (Pubitemid 38703845)
6. Peltola VT, McCullers JA (2004) Respiratory viruses predisposing to bacterial infections: role of +neuraminidase. Pediatr Infect Dis J 23:S87-S97 (Pubitemid 38168916)
7. Murphy TF (2006) The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 19:225-230 (Pubitemid 43740359)
8. Murphy TF (2003) Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 16:129-134 (Pubitemid 36521025)
9. Bandi V, Jakubowycz M, Kinyon C, Mason EO, Atmar RL, Greenberg SB, Murphy TF (2003) Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 37:69-75 (Pubitemid 36588929)
10. St Geme JW 3rd (2000) The pathogenesis of non-typeable Haemophilus influenzae otitis media. Vaccine 19:S41-S50 (Pubitemid 32121719)
11. National Heart, Lung and Blood Institute (1998) Morbidity and mortality chartbook on cardiovascular, lung and blood diseases. National Institutes of Health, 1998 Bethesda, MD
12. Gross CP, Anderson GF, Powe NR (1999) The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 340:1881-1887 (Pubitemid 29272669)
13. Vollmer WM, Osborne ML, Buist AS (1998) Twenty year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med 157:1079-1084
14. Janson C, Chinn S, Jarvis D, Zock JP, Toren K, Burney P (2001) Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Health Survey: a cross-sectional study. Lancet 358:2103-2109 (Pubitemid 34094898)
15. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC (2001) Smoking and airway inflammation in patients with mild asthma. Chest 120:1917-1922 (Pubitemid 34053454)
16. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L (2005) Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 175:2684-2691 (Pubitemid 41113884)
17. Larsson L, Szponar B, Ridha B, Pehrson C, Dutkiewicz J, Krysinska-Traczyk E, Sitkowska J (2008) Identification of bacterial and fungal components in tobacco and tobacco smoke. Tob Induc Dis 4:4
18. Li YT, He B, Wang YZ (2009) Exposure to cigarette smoke upregulates AP-1 activity and induces TNF-alpha overexpression in mouse lungs. Inhal Toxicol 21:641-647
19. Shizu M, Itoh Y, Sunahara R, Chujo S, Hayashi H, Ide Y, Takii T, Koshiko M, Chung SW, Hayakawa K, Miyazawa K, Hirose K, Onozaki K (2008) Cigarette smoke condensate upregulates the gene and protein expression of pro-inflammatory cytokines in human fibroblast-like synoviocyte line. J Interferon Cytokine Res 28:509-521
20. Mortaz E, Kraneveld AD, Smit JJ, Kool M, Lambrecht BN, Kunkel SL, Lukacs NW, Nijkamp FP, Folkerts G (2009) Effect of cigarette smoke extract on dendritic cells and their impact on T-cell proliferation. PLoS ONE 4:e4946
21. Leeder SR (1975) Role of infection in the cause and course of chronic bronchitis and emphysema. J Infect Dis 131:731-742
22. Tager I, Speizer FE (1975) Role of infection in chronic bronchitis. N Engl J Med 292:563-571
23. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriquez-Roisin R (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157:1498-1505
24. Sethi S, Murphy TF (2001) Bacterial infection in chronic obstructive pulmonary disease in 2000: a State-of-the-Art Review. Clin Microbiol Rev 14:336-363 (Pubitemid 32294674)
25. Murphy TF (2003) Respiratory infections caused by non-typeable Haemophilus influenzae. Curr Opin Infect Dis 16:129-134 (Pubitemid 36521025)
26. Stampfli MR, Anderson GP (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9:377-384
27. Domagala-Kulawik J (2008) Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol 59:19-34
28. Mehta H, Nazzal K, Sadikot RT (2008) Cigarette smoking and innate immunity. Inflamm Res 57:497-503
29. Thomson NC, Chaudhuri R (2009) Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 15:39-45
30. Holt PG (1987) Immune and inflammatory function in cigarette smokers. Thorax 42:241-249 (Pubitemid 17058936)
31. Arcavi L, Benowitz NL (2004) Cigarette smoking and infection. Arch Intern Med 164:2206-2216 (Pubitemid 39452980)
32. Smith CJ, Hansch C (2000) The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol 38:637-646 (Pubitemid 30624144)
33. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS (2000) Monocyte chemo-attractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 190:619-626 (Pubitemid 30164493)
34. Edwards D (2009) Immunological effects of tobacco smoking in "healthy" smokers. COPD 6:48-58
35. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ (2002) Alveolar macrophage-mediated elastolysis: roles of matrix metallopro-teinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 283: L867-L873
36. De Serres G, Lampron N, La Forge J, Rouleau I, Bourbeau J, Weiss K, Barret B, Boivin G (2009) Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 46:129-133
37. Skold CM, Lundahl J, Hallden G, Hallgren M, Eklund A (1996) Chronic smoke exposure alters the phenotype pattern and the metabolic response in human alveolar macrophages. Clin Exp Immunol 106:108-113 (Pubitemid 26329388)
38. Mancini NM, Bene MC, Gerard H, Chabot F, Faure G, Polu JM, Lesur O (1993) Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids. Lung 171:277-291 (Pubitemid 23251258)
39. Yamaguchi E, Itoh A, Furuya K, Miyamoto H, Abe S, Kawakami Y (1993) Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers. Chest 103:479-483 (Pubitemid 23070749)
40. Ohta T, Yamashita N, Maruyama M, Sugiyama E, Kobayashi M (1998) Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages. Respir Med 92:922-927 (Pubitemid 28401218)
41. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN (2007) Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 37:748-755 (Pubitemid 350211645)
42. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, Hacken J, Espada R, Bag R, Lewis DE, Kheradmand F (2004) An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med 1:e8
43. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD (1997) Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277:2002-2004 (Pubitemid 27449144)
44. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B (2005) Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 6:68
45. Heguy A, O'Connor TP, Luettich K, Worgall S, Cieciuch A, Harvey BG, Hackett NR, Crystal RG (2006) Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 84:318-328
46. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, Paquet AC, Erle DJ (2005) A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 172:1383-1392 (Pubitemid 43069811)
47. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG (1995) Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152:1666-1672 (Pubitemid 3002087)
48. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645-2653 (Pubitemid 38787999)
49. Van Hove CL, Moerloose K, Maes T, Joos GF, Tournoy KG (2008) Cigarette smoke enhances Th-2 driven airway inflammation and delays inhalational tolerance. Respir Res 9:42
50. Kroening PR, Barnes TW, Pease L, Limper A, Kita H, Vassallo R (2008) Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. J Immunol 181:1536-1547
51. Wang RD, Wright JL, Churg A (2005) Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 33:387-393 (Pubitemid 41416289)
52. Kalra R, Singh SP, Savage SM, Finch GL, Sopori ML (2000) Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther 293:166-171 (Pubitemid 30180936)
53. Hodge S, Hodge G, Holmes M, Reynolds PN (2005) Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 25:447-454 (Pubitemid 40331174)
54. Domagala-Kulawik J, Hoser G, Dabrowska M, Chazan R (2007) Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med 101:1338-1343 (Pubitemid 46667656)
55. Gross P, Pfitzer E, Tolker E, Babyak M, Kaschak M (1965) Experimental emphysema: its production with papain in normal and silicotic rats. Arch Environ Health 11:50-58
56. D'Armiento J, Dalal SS, Okada Y, Berg RA, Chada K (1992) Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71:955-961
57. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA (2000) Inducible targeting of IL-13 to adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 106:1081-1093
58. Wang Z, Zheng T, Zhu Z, Homer RJ, Riese RJ, Chapman HA Jr, Shapiro SD, Elias JA (2000) Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192:1587-1600
59. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D (2003) Loss of integrin alpha(v)beta(6)-mediated TGF-beta activation causes MMP12-dependent emphysema. Nature 422:169-173 (Pubitemid 36362749)
60. Moghaddam SJ, Clement CG, De la Garza MM, Zou X, Travis EL, Young HW, Evans CM, Tuvim MJ, Dickey BF (2008) Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am J Respir Cell Mol Biol 38:629-638 (Pubitemid 351841563)
61. Murphy TF, Sethi S, Neiderman MS (2000) The role of bacteria in exacerbations of COPD. Chest 118:204-209
62. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, MacCallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1618-1623 (Pubitemid 33124148)
63. Centers for Disease Control (2004) Updated interim influenza vaccination recommendations: 2004-05 influenza season. http://www.cdc.gov/flu. Accessed 31 Dec 2004
64. Advisory Committee of Immunization Practices (2005) Prevention and control of influenza: recommendations of the advisory committee of immunization practices. MMWR 54:1-40
65. Razani-Boroujerdi S, Singh SP, Knall C, Hahn FF, Pena-Philippides JC, Kalra R, Langley RJ, Sopori ML (2004) Chronic nicotine inhibits inflammation and promotes influenza infection. Cell Immunol 230:1-9 (Pubitemid 39482356)
66. Matsunaga K, Klein TW, Friedman H, Yamamoto Y (2001) Involvement of nicotinic acetyl-choline receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 167:6518-6524 (Pubitemid 33081587)
67. Goulding J, Snelgrove R, Saldana J, Didierlaurent A, Cavanagh M, Gwyer E, Wales J, Wissinger EL, Hussell T (2007) Respiratory infections: do we ever recover?. Proc Am Thorac Soc 4:618-625 (Pubitemid 350291624)
68. Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, Antignac A, Deghmane AE, Huerre M, Taha MK (2003) A model of meningococcal bacteremia after respiratory superin-fection in influenza A virus-infected mice. FEMS Microbiol Lett 222:99-106 (Pubitemid 36577358)
69. Hakansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C (1994) Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun 62:2707-2714 (Pubitemid 24203951)
70. Ratner AJ, Lysenko ES, Paul MN, Weiser JN (2005) Synergistic pro-inflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci 102:3429-3434 (Pubitemid 40328062)
71. Okamoto S, Kawabata S, Nakagawa I, Okuno Y, Goto T, Sano K, Hamada S (2003) Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J Virol 77:4104-4112 (Pubitemid 36350950)
72. Sun K, Metzger DW (2008) Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 14:558-564 (Pubitemid 351655219)